论文部分内容阅读
现今,过氧化物酶体增值物激活受体PPARδ激动剂(如:GW1516)和过氧化物酶体增殖物激活受体δ-AMP一激活的蛋白激酶(AMPK)轴激动剂(如:AICAR)受到了兴奋剂检测的关注,它们被证实可以促进骨骼肌纤维的氧化能力,提高肌肉耐力。因此2009年1月,世界反兴奋剂组织AICAR和GW1516加入到兴奋剂禁用清单中,并且归类为代谢调节剂~([1]),2012年反兴奋剂清单作出了一些调整,将这两种药物归类为代谢调节剂~([1])。在2012年的兴奋剂禁用清单中,还有一类S0未获批的物质,这类物质是未经任何
Nowadays, peroxisome proliferator-activated receptor PPARδ agonists (such as GW1516) and peroxisome proliferator-activated receptor δ-AMP-activated protein kinase (AMPK) axis agonists (such as AICAR) Stimulated by doping tests, they have been shown to promote skeletal muscle fiber oxidation and increase muscle endurance. As a result, World Anti-Doping Organization AICAR and GW1516 joined the doping disablement list in January 2009 and are classified as metabolic regulators ~ ([1]), making some adjustments to the 2012 anti-doping list The drugs are classified as metabolic regulators ~ ([1]). In the 2012 doping ban, there is also a list of substances not approved for S0, which have not been